NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Excerpt
Digital breast tomosynthesis (DBT) has rapidly been adopted by many providers of mammography screening in the United States. This report summarizes the evidence published through October 2015 regarding the diagnostic test characteristics of tomosynthesis in screening populations.
Contents
Prepared for: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services1. Contract No. HHSA-290-2012-00015-I, Task Order No. 5. Prepared by: Center for Healthcare Policy and Research2, Kaiser Permanente Research Affiliates Evidence-based Practice Center3
Suggested citation:
Melnikow J, Fenton JJ, Miglioretti D, Whitlock EP, Weyrich MS. Screening for Breast Cancer With Digital Breast Tomosynthesis. Evidence Synthesis No. 125. AHRQ Publication No. 14-05201-EF-2. Rockville, MD: Agency for Healthcare Research and Quality; 2016.
This report is based on research conducted by the University of California, Davis Center for Healthcare Policy and Research and the Kaiser Permanente Research Affiliates Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (HHSA-290-2012-00015-I, Task Order No. 5). The findings and conclusions in this document are those of the authors, who are responsible for its contents, and do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services.
The information in this report is intended to help health care decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment. Anyone who makes decisions concerning the provision of clinical care should consider this report in the same way as any medical reference and in conjunction with all other pertinent information (i.e., in the context of available resources and circumstances presented by individual patients).
This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or as a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.
This document is in the public domain and may be used and reprinted without permission except those copyrighted materials that are clearly noted in the document. Further reproduction of those copyrighted materials is prohibited without the specific permission of copyright holders.
None of the investigators has any affiliations or financial involvement that conflicts with the material presented in this report.
- 1
5600 Fishers Lane, Rockville, MD 20857; www
.ahrq.gov - 2
University of California, Davis, Sacramento, CA
- 3
Kaiser Permanente Center for Health Research, Portland, OR
- NLM CatalogRelated NLM Catalog Entries
- Review Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force[ 2016]Review Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Service Task ForceMelnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K. 2016 Jan
- Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.[JAMA Oncol. 2016]Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.McDonald ES, Oustimov A, Weinstein SP, Synnestvedt MB, Schnall M, Conant EF. JAMA Oncol. 2016 Jun 1; 2(6):737-43.
- Value Analysis of Digital Breast Tomosynthesis for Breast Cancer Screening in a US Medicaid Population.[J Am Coll Radiol. 2017]Value Analysis of Digital Breast Tomosynthesis for Breast Cancer Screening in a US Medicaid Population.Miller JD, Bonafede MM, Herschorn SD, Pohlman SK, Troeger KA, Fajardo LL. J Am Coll Radiol. 2017 Apr; 14(4):467-474.e5. Epub 2017 Jan 27.
- Baseline Screening Mammography: Performance of Full-Field Digital Mammography Versus Digital Breast Tomosynthesis.[AJR Am J Roentgenol. 2015]Baseline Screening Mammography: Performance of Full-Field Digital Mammography Versus Digital Breast Tomosynthesis.McDonald ES, McCarthy AM, Akhtar AL, Synnestvedt MB, Schnall M, Conant EF. AJR Am J Roentgenol. 2015 Nov; 205(5):1143-8.
- Review Digital breast tomosynthesis (3D-mammography) screening: data and implications for population screening.[Expert Rev Med Devices. 2015]Review Digital breast tomosynthesis (3D-mammography) screening: data and implications for population screening.Houssami N. Expert Rev Med Devices. 2015 Jul; 12(4):377-9. Epub 2015 May 31.
- Screening for Breast Cancer With Digital Breast TomosynthesisScreening for Breast Cancer With Digital Breast Tomosynthesis
- Substance Abuse Treatment and Family TherapySubstance Abuse Treatment and Family Therapy
- TPA_inf: Solanum ambosinum isolate ambI-C2R3 5S ribosomal RNA gene, partial sequ...TPA_inf: Solanum ambosinum isolate ambI-C2R3 5S ribosomal RNA gene, partial sequence; 5S rRNA intergenic spacer, complete sequence; and 5S ribosomal RNA gene, partial sequencegi|2240202256|tpg|BK059450.1|Nucleotide
- Penstemon auriberbis internal transcribed spacer 1, partial sequence; 5.8S ribos...Penstemon auriberbis internal transcribed spacer 1, partial sequence; 5.8S ribosomal RNA gene, complete sequence; and internal transcribed spacer 2, partial sequencegi|108795350|gb|DQ534929.1|Nucleotide
- Caspofungin - Drugs and Lactation Database (LactMed®)Caspofungin - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...